NewEdge Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24K Buy
244
+200
+455% +$2.23K ﹤0.01% 3892
2026
Q1
$477 Hold
44
﹤0.01% 3999
2025
Q4
$269 Hold
44
﹤0.01% 4119
2025
Q3
$228 Hold
44
﹤0.01% 4002
2025
Q2
$261 Sell
44
-309
-88% -$1.86K ﹤0.01% 3864
2025
Q1
$2.9K Hold
353
﹤0.01% 3430
2024
Q4
$2.92K Buy
353
+309
+702% +$2.48K ﹤0.01% 3378
2024
Q3
$337 Sell
44
-51
-54% -$470 ﹤0.01% 3647
2024
Q2
$984 Hold
95
﹤0.01% 3471
2024
Q1
$1.13K Hold
95
﹤0.01% 3474
2023
Q4
$1.03K Hold
95
﹤0.01% 3460
2023
Q3
$1.31K Hold
95
﹤0.01% 3129
2023
Q2
$1.14K Hold
95
﹤0.01% 3219
2023
Q1
$1.11K Sell
95
-370
-80% -$5.4K ﹤0.01% 3142
2022
Q4
$6.23K Buy
+465
New +$7.67K ﹤0.01% 2520

Other funds holding PTEN

NewEdge Advisors's PTEN Position: Q2 2026 in Review

NewEdge Advisors increased its Patterson-UTI (PTEN) stake by 455% in Q2 2026, buying an estimated $2.23K and bringing the position to 244 shares worth $2.24K. The position accounts for ﹤0.01% of the portfolio, ranked #3892.

NewEdge Advisors first reported a position in PTEN in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.23K in Q4 2022. 324 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • NewEdge Advisors held 244 shares of Patterson-UTI worth $2.24K as of Q2 2026.
  • NewEdge Advisors bought 200 Patterson-UTI shares in Q2 2026, an estimated $2.23K.
  • Patterson-UTI made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3892 holding.
  • NewEdge Advisors first reported a position in Patterson-UTI in Q4 2022 and has held it in 15 quarters since.
  • NewEdge Advisors's Patterson-UTI position peaked at $6.23K in Q4 2022.
  • 324 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.